It does not mean every patient needs the same hold period
Though, you may need to return eventually for another dose
In patients with type 2 diabetes, treatment with semaglutide 1 mg resulted in reductions in glucose in terms of absolute change from baseline and relative reduction compared to placebo of 29 mg/dL (22%) for fasting glucose, 74 mg/dL (36%) for 2-hour postprandial glucose, and 30 mg/dL (22%) for mean 24-hour glucose concentration (see Figure 1 )
This spacing window is already standard practice for levothyroxine dosing
A semaglutide 6mg research pen is a pre-filled, dose-validated subcutaneous injection device containing 6 mg of synthetic semaglutide peptide, supplied for in vitro and non-human laboratory investigation of GLP-1 receptor agonist pharmacology
At hol+, we dont just treat the body, we support the whole person